H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect

H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an important treatment for many types of hematological malignancies. Matching of donor and recipient for the major histocompatibility complex (MHC) improves the HSCT reconstitution, but donor-derived T cells reactive to non-MHC encode...

Full description

Bibliographic Details
Main Authors:	Eun Young Choi, Kyungho Choi, Giri Nam, Woojin Kim, Minho Chung
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-06-01
Series:	Frontiers in Immunology
Subjects:	H60 minor histocompatibility antigen graft-versus-leukemia graft-versus-host-disease hematopoieic cell-restricted antigen
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.01163/full

Similar Items

Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens
by: Kyra J. Fuchs, et al.
Published: (2020-04-01)

Autosomal minor histocompatibility antigens; How genetic variants create diversity in immune targets
by: Marieke eGriffioen, et al.
Published: (2016-03-01)

Does minor histocompatibility antigen HA-1 disparity affect the occurrence of graft-versus-host disease in tunisian recipients of hematopoietic stem cells?
by: Mohamed Hichem Sellami, et al.
Published: (2010-01-01)

Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation
by: Motoko Koyama, et al.
Published: (2021-09-01)

Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
by: Sena Kim, et al.
Published: (2020-06-01)

The Graft-Versus-Leukemia Effect in AML
by: Connor Sweeney, et al.
Published: (2019-11-01)

Paving the Way Towards Universal Chimeric Antigen Receptor Therapy in Cancer Treatment: Current Landscape and Progress
by: Yixi Zhang, et al.
Published: (2020-12-01)

Minor Histocompatibility Antigen-Specific T Cells
by: Corinne Summers, et al.
Published: (2020-06-01)

NOTCH and Graft-Versus-Host Disease
by: Mauro Di Ianni, et al.
Published: (2018-08-01)

Scabies mimicking graft versus host disease in a hematopoietic cell transplant recipient
by: Dongsub Kim, et al.
Published: (2018-11-01)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
by: Linlu Tian, et al.
Published: (2022-08-01)

Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?
by: Jacob Rozmus, et al.
Published: (2022-03-01)

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
by: Yuan Song, et al.
Published: (2020-10-01)

Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives
by: Israel Henig, et al.
Published: (2014-10-01)

Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment
by: Ane Orrantia, et al.
Published: (2021-03-01)

CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model
by: Ji-Young Lim, et al.
Published: (2020-06-01)

Current status of research and treatment of dry eye associated with chronic ocular graft-versus-host disease
by: Yuan Liang, et al.
Published: (2022-12-01)

Hydrogen in Patients With Corticosteroid-Refractory/Dependent Chronic Graft-Versus-Host-Disease: A Single-Arm, Multicenter, Open-Label, Phase 2 Trial
by: Liren Qian, et al.
Published: (2020-11-01)

MicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease
by: Christian Koenecke, et al.
Published: (2018-05-01)

Biomarkers for Allogeneic HCT Outcomes
by: Djamilatou Adom, et al.
Published: (2020-04-01)

Frequency of Major Histocompatibility Antigens Class I in Mazandaran Province
by: Fatemeh Toghani Hulari, et al.
Published: (2022-04-01)

Immune reconstitution after hematopoietic stem cell transplantation
by: Justyna Ogonek, et al.
Published: (2016-11-01)

Commentary: Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation
by: Jessica Stokes, et al.
Published: (2022-04-01)

Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation
by: Ying Yang, et al.
Published: (2022-09-01)

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells
by: Yong-Rim Kwon, et al.
Published: (2020-09-01)

Vitiligo: an uncommon cutaneous manifestation of graft versus host disease
by: Preema Sinha, et al.
Published: (2022-01-01)

Separation of GVL from GVHD -location, location, location
by: Takanori Teshima, et al.
Published: (2023-12-01)

Ocular graft-versus-host disease: An update on immune pathogenesis and therapies
by: Samantha P. Peña-Lozano, et al.
Published: (2022-07-01)

Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration
by: Yang Gao, et al.
Published: (2021-12-01)

Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease
by: Fathima A. Mohamed, et al.
Published: (2021-10-01)

Donor lymphocyte infusion in bone marrow transplantation therapy
by: Stephen Mackinnon, et al.
Published: (2002-04-01)

Lichenoid variant of chronic cutaneous graft versus host reaction post blood transfusion: A rare event post blood transfusion
by: Pushpa Kodipalya Ramakrishnaiah, et al.
Published: (2015-01-01)

The Elephant in The Room: AML Relapse Post Allogeneic Hematopoietic Cell Transplantation
by: Iman Abou Dalle, et al.
Published: (2022-01-01)

Facing challenges with hope: universal immune cells for hematologic malignancies
by: Yuqing Wang, et al.
Published: (2023-04-01)

Consequence of Histoincompatibility beyond GvH-Reaction in Cytomegalovirus Disease Associated with Allogeneic Hematopoietic Cell Transplantation: Change of Paradigm
by: Matthias J. Reddehase, et al.
Published: (2021-08-01)

Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation
by: Ashley D. Hadjis, et al.
Published: (2022-02-01)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
by: Natalie Köhler, et al.
Published: (2021-03-01)

Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice
by: Chloe Sligar, et al.
Published: (2024-01-01)

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
by: Linde Dekker, et al.
Published: (2022-06-01)

Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl Fumarate
by: Jingjing Han, et al.
Published: (2017-11-01)